Drugs / D-3263
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00839631 | Mar 2009 → Dec 2011 | cancer | Dendreon | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | D-3263 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00839631 ↗ |
| Known as | D-3263 (FREE BASE) | ChEMBL registry synonym — accepted as the source's own label CHEMBL3707315 ↗ |
| Known as | EC D-3263 HCl | “EC D-3263 HCl, capsules, 50 mg.” NCT00839631 ↗ |
| Action | Activate | “Transient receptor potential cation channel subfamily M member 8 agonist” CHEMBL3707315 ↗ |
| Route | Oral | “Oral administration.” NCT00839631 ↗ |
| Target | TRPM8 | “Transient receptor potential cation channel subfamily M member 8 agonist” CHEMBL3707315 ↗ |